🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary immunogenicity objective is to assess and compare the immunogen...
Status
Completed
Location
Site 22
Start Date
2008-03
Trial ID
NCT00667602
Treatments Being Tested
Based on the Phase I trial completed by the sponsor, the Phase II clinical ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-06
Trial ID
NCT06426056
Treatments Being Tested
The purpose of this study is to evaluate the safeness and effectiveness of ...
Status
Completed
Location
Biological treatment center in Fuda cancer hospital
Start Date
2015-01
Trial ID
NCT02338700
Treatments Being Tested
This is an open label study designed to examine the effects on concurrent a...
Status
Completed
Location
Chesapeake urology Research Associates
Start Date
2014-03
Trial ID
NCT02097303
Treatments Being Tested
The EpiFinder device, which is the investigational device in this study, is...
Status
Unknown
Location
Rambam Medical Center
Start Date
2019-12-15
Trial ID
NCT04047927
Treatments Being Tested
The primary objective is to evaluate the efficacy of desensitization therap...
Status
Terminated
Location
Cedars Sinai Heart Institute
Start Date
2013-06
Trial ID
NCT01769443
Treatments Being Tested
Investigators want to use 18F-FDG PET/CT imaging to reflect tumor perfusion...
Status
Unknown
Location
Yingying Sun
Start Date
2016-11-01
Trial ID
NCT03373994
Treatments Being Tested
This study will evaluate the immunogenicity, safety, and tolerability of VA...
Status
Completed
Location
Alabama Clinical Therapeutics ( Site 0018)
Start Date
2017-10-17
Trial ID
NCT03239873
Treatments Being Tested
Background: A neuroendocrine tumor is a rare type of tumor. It comes from ...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2022-10-03
Trial ID
NCT04086485
Treatments Being Tested
The goal of this clinical trial is to learn if add SHR-A1811 and/or Adebrel...
Status
Not Yet Recruiting
Location
National Cancer Center/Cancer hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2026-02-15
Trial ID
NCT07317778